Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of vitamin D, omega-3 fatty acids, and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial.
Bischoff-Ferrari HA, Freystätter G, Vellas B, Dawson-Hughes B, Kressig RW, Kanis JA, Willett WC, Manson JE, Rizzoli R, Theiler R, Hofbauer LC, Armbrecht G, da Silva JAP, Blauth M, de Godoi Rezende Costa Molino C, Lang W, Siebert U, Egli A, Orav EJ, Wieczorek M; DO-HEALTH Research Group. Bischoff-Ferrari HA, et al. Among authors: vellas b. Am J Clin Nutr. 2022 May 1;115(5):1311-1321. doi: 10.1093/ajcn/nqac022. Am J Clin Nutr. 2022. PMID: 35136915 Free article. Clinical Trial.
Response to the letter to the editor entitled "What is missing in the validation of frailty instruments?" by Drs Xue and Varadhan: The Toulouse frailty clinic, 1 year of clinical experience.
van Kan GA, Guyonnet S, Ghisolfi A, Subra J, Chicoullaa B, Lilamand M, Cesari M, Vellas B. van Kan GA, et al. Among authors: vellas b. J Am Med Dir Assoc. 2014 Feb;15(2):147-9. doi: 10.1016/j.jamda.2013.11.021. J Am Med Dir Assoc. 2014. PMID: 24461246 No abstract available.
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group. Andrieu S, et al. Among authors: vellas b. Lancet Neurol. 2017 May;16(5):377-389. doi: 10.1016/S1474-4422(17)30040-6. Epub 2017 Mar 27. Lancet Neurol. 2017. PMID: 28359749 Clinical Trial.
1,117 results